| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/16/2011 | US20110144092 Substituted alkyl pyrimidin-4-one derivatives |
| 06/16/2011 | US20110144077 Treatment of retinal degeneration |
| 06/16/2011 | US20110144074 Caspase inhibitors and uses thereof |
| 06/16/2011 | US20110144073 Glucocorticoids attached to nitrate esters via an aromatic linker in position 21 and their use in ophthalmology |
| 06/16/2011 | US20110144035 Methods and Compositions for Treating Conditions of the Eye |
| 06/16/2011 | US20110143995 Novel anti-allergic agents |
| 06/16/2011 | US20110143993 Endothelial basement membrane targeting peptide ligands |
| 06/16/2011 | US20110143991 Peptides for Activation and Inhibition of Delta-PKC |
| 06/16/2011 | US20110142948 Nanoparticle Carrier Systems based on Human Serum Albumin for Photodynamic Therapy |
| 06/16/2011 | US20110142923 Ophthalmic pharmaceutical compositions for the treatment of neoangiogenic pathologies of the eye |
| 06/16/2011 | US20110142918 Anti-angiogenic compositions and therapeutic applications thereof |
| 06/16/2011 | US20110142917 Compositions and methods for treatment of ear disorders |
| 06/16/2011 | US20110142908 Ophthalmic Device, and Method of Use Thereof, for Increasing Ocular Boundary Lubrication |
| 06/16/2011 | US20110142890 Nanoparticles of chitosan and hyaluronan for the administration of active molecules |
| 06/16/2011 | US20110142886 Pegylated polyplexes for polynucleotide delivery |
| 06/16/2011 | US20110142867 Immunotherapeutic methods and systems |
| 06/16/2011 | US20110142856 Compound containing basic group and use thereof |
| 06/16/2011 | US20110142834 Treatment of hearing and balance impairments using compounds having erythropoietin activity |
| 06/16/2011 | US20110142831 Use of il-23 and il-17 antagonists to treat autoimmune ocular inflammatory disease |
| 06/16/2011 | US20110142821 Roles for dual endothelin-1/angiotensin ii receptor (dear) in hypertension and angiogenesis |
| 06/16/2011 | US20110142766 Effervescent Multi-Vitamin Formulation and Methods of Use Thereof |
| 06/16/2011 | DE102009058325A1 Extract of a plant of Brassica, useful for increasing antioxidant activity of epithelial tissue e.g. epithelial tissue of skin or preventing and treating eye diseases e.g. macular degeneration or cataract and preventing eating disorders |
| 06/16/2011 | CA2785996A1 Sr-bi as a predictor of human female infertility and responsiveness to treatment |
| 06/16/2011 | CA2784005A1 Nanoparticle carrier systems based on poly(dl-lactic-co-glycolic acid) (plga) for photodynamic therapy (pdt) |
| 06/16/2011 | CA2783958A1 Oxazine derivative |
| 06/16/2011 | CA2783707A1 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |
| 06/16/2011 | CA2783699A1 Compounds and methods of treating ocular disorders |
| 06/16/2011 | CA2783537A1 Benzamide compound |
| 06/16/2011 | CA2782015A1 Compositions and methods for the treatment of macular degeneration |
| 06/15/2011 | EP2332922A1 N-substituted azoles and their use as MEK-1 and/or ERK-2 modulators |
| 06/15/2011 | EP2332550A1 Tetracyclines for the treatment of neurodegenerative diseases |
| 06/15/2011 | EP2332549A1 Novel tetracyclines and their use in medicine |
| 06/15/2011 | EP2332548A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332547A1 Tetracyclines for the treatment of inflammatory bowel disease |
| 06/15/2011 | EP2332546A1 Tetracyclines for the treatment of stroke |
| 06/15/2011 | EP2332541A1 Use of thioxanthine derivatives as MPO inhibitors |
| 06/15/2011 | EP2332540A1 Administration of ranolazine for the treatment of diabetes |
| 06/15/2011 | EP2332536A1 Inhibitors of protein tyrosine kinase activity |
| 06/15/2011 | EP2332424A1 Method for producing lipid |
| 06/15/2011 | EP2331521A1 Therapeutic compounds |
| 06/15/2011 | EP1717229B1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein |
| 06/15/2011 | EP1598371B1 Medicinal composition for ophthalmic use containing acetylated hyaluronic acid |
| 06/15/2011 | EP1349558B1 Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
| 06/15/2011 | EP1175400B1 Renin inhibitors |
| 06/15/2011 | EP0835110B2 Use of (2-imidazolin-2-ylamino) quinoxalines in treating ocular neural injury |
| 06/15/2011 | CN201861291U Technological cotton health-care pillow |
| 06/15/2011 | CN1832948B 1- alkyl-1-azoniabicyclo (2.2.2) octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 06/15/2011 | CN1830462B Erycibes extraction, medicinal composition containing said oxtraction and its preparation method |
| 06/15/2011 | CN102099330A Nitric oxide donating prostamides |
| 06/15/2011 | CN102099037A Stable aqueous solution composition containing sulfonamide compound |
| 06/15/2011 | CN102099029A Formulations for treating eye disorders |
| 06/15/2011 | CN102099013A Controlled-release apoptosis modulating compositions and methods for the treatment of otic disorders |
| 06/15/2011 | CN102093421A Phosphorus substituent group-containing quinoline compound and preparation method of quinoline compound as well as pharmaceutical composition containing quinoline compound and application of pharmaceutical composition |
| 06/15/2011 | CN102093353A 7-substituted aza-indazoles, compositions containing same, production method and use thereof |
| 06/15/2011 | CN102091330A Pharmaceutical compositions comprising valsartan and NEP inhibitors |
| 06/15/2011 | CN102091223A Traditional Chinese medicine for treating diabetic eye diseases |
| 06/15/2011 | CN102091214A Medicament for improving eyesight |
| 06/15/2011 | CN102091212A Traditional Chinese medicine decoction for treating recurrent central serous chorioretinopathy |
| 06/15/2011 | CN102091192A Chinese medicine composition for treating cataract |
| 06/15/2011 | CN102091170A Traditional Chinese medicine for treating diabetic retinopathy |
| 06/15/2011 | CN102091135A Bezoar antidotal pills (tables and capsules) containing bezoar cultured in vitro and preparation method thereof |
| 06/15/2011 | CN102091132A Method for detecting esculin, aesculetin, fraxin and fraxetin in cortex fraxini or extract thereof |
| 06/15/2011 | CN102091055A Calcium dobesilate capsule and preparation method thereof |
| 06/15/2011 | CN102090636A PUFA supplements |
| 06/15/2011 | CN101766792B Chinese herbal composite for deafness treatment and preparation method thereof |
| 06/15/2011 | CN101690712B Sitafloxacin eye drop and preparation method thereof |
| 06/15/2011 | CN101647913B Traditional Chinese medicine preparation for treating senile cataract and viral keratitis |
| 06/15/2011 | CN101647908B Chinese traditional medicine for treating eyesight and preparation method and use method thereof |
| 06/15/2011 | CN101537077B Chinese medicinal mixed tincture |
| 06/15/2011 | CN101317894B Emplastrum for applied on acupuncture points and preparation method thereof |
| 06/15/2011 | CN101137383B 增强型比马前列素眼用溶液 Enhanced bimatoprost ophthalmic solution |
| 06/15/2011 | CN101048156B Inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases |
| 06/14/2011 | US7960433 Treatment of chemokine mediated diseases |
| 06/14/2011 | US7960416 Oil-in-water emulsion of a 1-carboxylate-6-arylsulfamoyl cyclohexene and synthetic and naturally occurring phospholipids; nitric oxide or cytokine prodution inhibitors; cardiovascular disorders, autoimmune dieseases, septic shock; improved stability during autoclave sterilization |
| 06/14/2011 | US7960369 Receptor function regulator |
| 06/14/2011 | US7959933 Activatable recombinant neurotoxins |
| 06/14/2011 | CA2526670C Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
| 06/14/2011 | CA2496676C 3,4-di-substituted cyclobutene-1,2-diones as cxc-chemokine receptor ligands |
| 06/14/2011 | CA2494962C Tyrosine kinase inhibitors |
| 06/14/2011 | CA2494241C Botulinum toxin pharmaceutical compositions |
| 06/14/2011 | CA2468704C Urea derivatives as angiogenesis inhibitors |
| 06/14/2011 | CA2451859C Substituted 1-oxa-2,8-diaza-spiro[4,5]dec-2-ene derivatives as medicaments for the treatment of pain |
| 06/14/2011 | CA2443325C Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators |
| 06/14/2011 | CA2437966C 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical |
| 06/14/2011 | CA2433667C Prodrugs of excitatory amino acids |
| 06/14/2011 | CA2430669C Synthesis of 3-amino-thalidomide and its enantiomers |
| 06/14/2011 | CA2428468C New 7-azaindoles, their use as inhibitors of phosphodiesterase 4, and a method for synthesizing them |
| 06/14/2011 | CA2426292C Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 06/09/2011 | WO2011068978A1 Methanocarba adenosine derivatives and dendrimer conjugates thereof |
| 06/09/2011 | WO2011068786A2 Treating xerophthalmia with compounds increasing meibomian gland secretion |
| 06/09/2011 | WO2011068211A1 2-pyridone compounds |
| 06/09/2011 | WO2011068171A1 Bicyclic nitrogen-containing saturated heterocyclic derivatives |
| 06/09/2011 | WO2011014661A3 Liver x receptor agonists |
| 06/09/2011 | US20110136912 Ophthalmic emulsion |
| 06/09/2011 | US20110136904 Prostaglandin derivatives |
| 06/09/2011 | US20110136898 Treatment of retinal degeneration |
| 06/09/2011 | US20110136884 Selective subtype alpha 2 adrenergic agents and methods for use thereof |
| 06/09/2011 | US20110136881 Novel Pyrrole Inhibitors of S-Nitrosoglutathione Reductase as Therapeutic Agents |
| 06/09/2011 | US20110136877 2-phenyl phenoxyacetic acids useful for treating inflammatory disorders |
| 06/09/2011 | US20110136872 Stable aqueous compositions of prostglandin agonist prodrugs and methods for use thereof |